232 related articles for article (PubMed ID: 19091619)
1. [Diagnostic and treatment delays do not modify the treatment outcome of patients with multiform glioblastoma].
Noël G; Quetin P; Heymann S; Karamanoukian D; Schott R
Cancer Radiother; 2009 Jan; 13(1):17-23. PubMed ID: 19091619
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.
Jeon HJ; Kong DS; Park KB; Lee JI; Park K; Kim JH; Kim ST; Lim DH; Kim WS; Nam DH
Clin Neurol Neurosurg; 2009 Oct; 111(8):679-82. PubMed ID: 19640635
[TBL] [Abstract][Full Text] [Related]
3. Retrospective comparison of chemoradiotherapy followed by adjuvant chemotherapy, with or without prior gliadel implantation (carmustine) after initial surgery in patients with newly diagnosed high-grade gliomas.
Noël G; Schott R; Froelich S; Gaub MP; Boyer P; Fischer-Lokou D; Dufour P; Kehrli P; Maitrot D
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):749-55. PubMed ID: 21300471
[TBL] [Abstract][Full Text] [Related]
4. Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy.
Noel G; Huchet A; Feuvret L; Maire JP; Verrelle P; Le Rhun E; Aumont M; Thillays F; Sunyach MP; Henzen C; Missohou F; de Crevoisier R; Bondiau PY; Collin P; Durando X; Truc G; Kerr C; Bernier V; Clavier JB; Atlani D; D'Hombres A; Vinchon-Petit S; Lagrange JL; Taillandier L
J Neurooncol; 2012 Aug; 109(1):167-75. PubMed ID: 22660920
[TBL] [Abstract][Full Text] [Related]
5. Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme.
Seidlitz A; Siepmann T; Löck S; Juratli T; Baumann M; Krause M
Radiat Oncol; 2015 Aug; 10():172. PubMed ID: 26276734
[TBL] [Abstract][Full Text] [Related]
6. [The effect of extent of tumor resection on the outcome of combined therapy in patients with glioblastoma multiforme].
Jeremić B; Grulicić D; Samardzić M; Antunović V; Joksimović M; Djurić Lj; Milicić B; Nikolić N
Srp Arh Celok Lek; 1997; 125(3-4):93-8. PubMed ID: 9221525
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in glioblastoma patients managed with radiotherapy combined with temozolomide.
Peponi E; Tourkantonis I; Tasiou I; Pavlidis N; Pentheroudakis G; Tsekeris P
J BUON; 2014; 19(3):718-23. PubMed ID: 25261658
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of carmustine wafers in combination with 6-month metronomic temozolomide and radiation therapy in newly diagnosed glioblastoma: preliminary results.
Salmaggi A; Milanesi I; Silvani A; Gaviani P; Marchetti M; Fariselli L; Solero CL; Maccagnano C; Casali C; Guzzetti S; Pollo B; Ciusani E; Dimeco F
J Neurosurg; 2013 Apr; 118(4):821-9. PubMed ID: 23350777
[TBL] [Abstract][Full Text] [Related]
9. A Survival Analysis with Identification of Prognostic Factors in a Series of 110 Patients with Newly Diagnosed Glioblastoma Before and After Introduction of the Stupp Regimen: A Single-Center Observational Study.
Illic R; Somma T; Savic D; Frio F; Milicevic M; Solari D; Nikitovic M; Lavrnic S; Raicevic S; Milosevic S; Cavallo LM; Cappabianca P; Grujicic D
World Neurosurg; 2017 Aug; 104():581-588. PubMed ID: 28522381
[TBL] [Abstract][Full Text] [Related]
10. Interdisciplinary treatment of glioblastoma: analysis of prognostic factors and treatment results in unselected patients.
Langsenlehner T; Groll MJ; Quehenberger F; Payer F; Mokry M; Kapp KS
Neoplasma; 2012; 59(6):662-8. PubMed ID: 22862166
[TBL] [Abstract][Full Text] [Related]
11. The impact of surgery on the efficacy of adjuvant therapy in glioblastoma multiforme.
Brzozowska A; Toruń A; Mazurkiewicz M
Adv Clin Exp Med; 2015; 24(2):279-87. PubMed ID: 25931361
[TBL] [Abstract][Full Text] [Related]
12. Patterns of care and survival in a retrospective analysis of 1059 patients with glioblastoma multiforme treated between 2002 and 2007: a multicenter study by the Central Nervous System Study Group of Airo (italian Association of Radiation Oncology).
Scoccianti S; Magrini SM; Ricardi U; Detti B; Buglione M; Sotti G; Krengli M; Maluta S; Parisi S; Bertoni F; Mantovani C; Tombolini V; De Renzis C; Lioce M; Fatigante L; Fusco V; Muto P; Berti F; Rubino G; Cipressi S; Fariselli L; Lupattelli M; Santoni R; Pirtoli L; Biti G
Neurosurgery; 2010 Aug; 67(2):446-58. PubMed ID: 20644432
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors other than the performance status and age for glioblastoma multiforme: a single-institution experience.
Caloglu M; Yurut-Caloglu V; Karagol H; Bayir-Angin G; Turan FN; Uzal C
J BUON; 2009; 14(2):211-8. PubMed ID: 19650168
[TBL] [Abstract][Full Text] [Related]
14. [Multivariate analysis of prognostic factors and survival in patients with "glioblastoma multiforme"].
Tramacere F; Gianicolo E; Serinelli M; Bambace S; De Luca M; Castagna R; Francavilla MC; Leone A; Monastero S; Fucilli F; Pili G; Distante A; Portaluri M
Clin Ter; 2008; 159(4):233-8. PubMed ID: 18776979
[TBL] [Abstract][Full Text] [Related]
15. Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme.
Chamberlain MC; Tsao-Wei DD
Cancer; 2004 Mar; 100(6):1213-20. PubMed ID: 15022289
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of temozolomide as adjuvant chemotherapy after postsurgical radiotherapy alone for glioblastomas.
Rhee DJ; Kong DS; Kim WS; Park KB; Lee JI; Suh YL; Song SY; Kim ST; Lim DH; Park K; Kim JH; Nam DH
Clin Neurol Neurosurg; 2009 Nov; 111(9):748-51. PubMed ID: 19716649
[TBL] [Abstract][Full Text] [Related]
17. Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma.
Stupp R; Hegi ME; Neyns B; Goldbrunner R; Schlegel U; Clement PM; Grabenbauer GG; Ochsenbein AF; Simon M; Dietrich PY; Pietsch T; Hicking C; Tonn JC; Diserens AC; Pica A; Hermisson M; Krueger S; Picard M; Weller M
J Clin Oncol; 2010 Jun; 28(16):2712-8. PubMed ID: 20439646
[TBL] [Abstract][Full Text] [Related]
18. Extent of surgical resection and adjuvant temozolomide improves survival in pediatric GBM: a single center experience.
Gupta S; Mallick S; Benson R; Haresh KP; Julka PK; Rath GK
Childs Nerv Syst; 2017 Jun; 33(6):951-956. PubMed ID: 28424876
[TBL] [Abstract][Full Text] [Related]
19. Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience.
Jalali R; Basu A; Gupta T; Munshi A; Menon H; Sarin R; Goel A
Br J Neurosurg; 2007 Dec; 21(6):583-7. PubMed ID: 18071985
[TBL] [Abstract][Full Text] [Related]
20. Distance to the neurooncological center: a negative prognostic factor in patients with glioblastoma multiforme. An epidemiological study.
Kerschbaumer J; Freyschlag CF; Bauer R; Obwegeser AA; Schubert GA; Thomé C; Seiz M
Anticancer Res; 2012 Dec; 32(12):5515-9. PubMed ID: 23225460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
